Kim DS - Search Results

1

Increase in transglutaminase 2 expression is associated with NF-kappaB activation in breast cancer tissues.

Park KS, Kim DS, Jeong KC, Kim SY. Park KS, et al. Among authors: kim ds, kim sy. Front Biosci (Landmark Ed). 2009 Jan 1;14(5):1945-51. doi: 10.2741/3354. Front Biosci (Landmark Ed). 2009. PMID: 19273176 Free article.

2

Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster.

Park SS, Kim JM, Kim DS, Kim IH, Kim SY. Park SS, et al. Among authors: kim ds, kim ih, kim jm, kim sy. J Biol Chem. 2006 Nov 17;281(46):34965-72. doi: 10.1074/jbc.M604150200. Epub 2006 Sep 20. J Biol Chem. 2006. PMID: 16987813 Free article.

3

Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.

Kim DS, Park SS, Nam BH, Kim IH, Kim SY. Kim DS, et al. Among authors: kim ih, kim sy. Cancer Res. 2006 Nov 15;66(22):10936-43. doi: 10.1158/0008-5472.CAN-06-1521. Cancer Res. 2006. PMID: 17108131

4

Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.

Kim DS, Park KS, Jeong KC, Lee BI, Lee CH, Kim SY. Kim DS, et al. Among authors: kim sy. Cancer Lett. 2009 Jan 18;273(2):243-9. doi: 10.1016/j.canlet.2008.08.015. Epub 2008 Sep 19. Cancer Lett. 2009. PMID: 18804908

5

Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.

Park KS, Han BG, Lee KH, Kim DS, Kim JM, Jeon H, Kim HS, Suh SW, Lee EH, Kim SY, Lee BI. Park KS, et al. Among authors: kim ds, kim jm, kim sy, kim hs. Cancer Lett. 2009 Feb 18;274(2):201-7. doi: 10.1016/j.canlet.2008.09.007. Epub 2008 Oct 11. Cancer Lett. 2009. PMID: 18851895

6

A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.

Kim JM, Voll RE, Ko C, Kim DS, Park KS, Kim SY. Kim JM, et al. Among authors: kim ds, kim sy. J Mol Biol. 2008 Dec 26;384(4):756-65. doi: 10.1016/j.jmb.2008.10.010. Epub 2008 Oct 11. J Mol Biol. 2008. PMID: 18950638

7

Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors.

Kim DS, Park KS, Kim SY. Kim DS, et al. Among authors: kim sy. Front Biosci (Landmark Ed). 2009 Jan 1;14(7):2514-21. doi: 10.2741/3394. Front Biosci (Landmark Ed). 2009. PMID: 19273216 Free article.

8

I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.

Kim DS, Han BG, Park KS, Lee BI, Kim SY, Bae CD. Kim DS, et al. Among authors: kim sy. Biochem Biophys Res Commun. 2010 Aug 20;399(2):300-6. doi: 10.1016/j.bbrc.2010.07.078. Epub 2010 Jul 24. Biochem Biophys Res Commun. 2010. PMID: 20659425

9

Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation.

Kim DS, Kim B, Tahk H, Kim DH, Ahn ER, Choi C, Jeon Y, Park SY, Lee H, Oh SH, Kim SY. Kim DS, et al. Among authors: kim b, kim dh, kim sy. Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):479-84. doi: 10.1016/j.bbrc.2010.11.063. Epub 2010 Nov 19. Biochem Biophys Res Commun. 2010. PMID: 21094133

10

TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.

Park KS, Kim DS, Ko C, Lee SJ, Oh SH, Kim SY. Park KS, et al. Among authors: kim ds, kim sy. Front Biosci (Elite Ed). 2011 Jan 1;3(1):341-54. doi: 10.2741/e249. Front Biosci (Elite Ed). 2011. PMID: 21196314 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,740 results

Search Page

Filters